LY3209590

Published

dm+d

Unassigned

New Medicines

Type 2 diabetes mellitus

Information

New molecular entity
Eli Lilly
Eli Lilly

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

A recombinant basal insulin fused to a Fc domain. The conjugated insulin is designed to provide a long-acting basal profile of the hormone.
In 2018–2019 there were 3,919,505 people diagnosed with diabetes. About 90% of adults currently diagnosed have type 2 diabetes. About one million people with type 2 diabetes are currently undiagnosed [1].
Type 2 diabetes mellitus
Subcutaneous injection